Informations techniques
Exploitant
Laboratoires PROSTRAKAN PHARMA
Présentation
DROLEPTAN 2,5 mg/ 1ml, solution injectable (IV) B/10 - CIP 561 122-8
eNq1mFFv2jAQx9/5FFHeSVJoSzoFqo21G1KrMlq0aS/IJEcxc+30bAPdp59DqEqnRG0NfgPb+d/Fd/75ryTn6wfmLQElFbzrHwWR7wFPRUb5fdcf3102Y/+810gWZEl2lnWCKDhq+V7KiJRdv5gNpkC4DH5dX30F8zyg32t4iZguIFWv1mlFWfCdyPk1yYs1XrIUNPMeQM1F1vVzrTajXiIVmix6K4F/ZE5SSMLtyO7sYnK8O56Ehdg7VLUEvCL8vlJ0hlaaqUYErvpEwb3Ap2rpdNKKO6dRFFuFoHIEUmhMYUjUfIhiSTPIqiMRJsEqyGyV3QIuGagiSKV4uEgfpJU4WZD1CB4H1Ul/NrN9tVbNqHnUOT5tRdHJWdyJWlahcGerqpvHvESY55hNWmfxSTvuhDMMMxQMckV40/zKAWkmmGWthgIVYY6qRGX/db85ioPw+GY3ZFTmjDwFC5nbbhVBYqYBDRXcvUjxBndoOMXMnv2nzzVj4QezHm8p4ijjAlJ9obmqgcnlyHYj+oIrWNdX1I5/ar3tRQrycLJ/Ba9m/1BPGU1tEWcgpEGq8WhQTziXcPhCJIzRHR1+Up6JlTw8dXar7Cj7fAPOStF80o5O4rO2/bX/2/RTzfVzoYuqhgZGVO7DmAGfiX3pYlq0Wuq5QZ315sYbiZQwqHFHTUvwmKZ8NnPO2t7dkSonKkW/XdzZtssPDfh0u/lbKU2z7m6h7cDsgvamP9/KvTzG3f2ObCnyDlN9HLftfKLGatTMlcrlpzBcrVbBnMimJGYbA3PS3n01nB9kBwxzXwrozvM78QSlRyqR6yj1aXmRfqyEtsf1LdewrxPePr913JUxFGrYoxYl2Z3xd3BxeKS/2GBnaQ9fUcZdmI1lJYoK7so66Wk1i/e9RExp+SUaRtzMZrTma0xtayZh+SWo10jC4itQr/EP9GoSgg==
5YW7VXgmEp2gmnaW